EP3129018
Meðhöndlun á NAFLD og NASH
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.4.2015EP published:
23.10.2019EP application number:
15728222.9
EP translation filed:
16.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
9.4.2035Expiry date:
9.4.2026Next due date:
30.4.2026
Title:
TREATMENT OF NAFLD AND NASH
Timeline
Today
10.4.2015EP application
23.10.2019EP Publication
16.12.2019Translation submitted
15.1.2020Registration published
9.4.2026Expires
Owner
Name:
CymaBay Therapeutics, Inc.Address:
7575 Gateway Boulevard, Suite 110, 94560, Newark, CA, US
Inventor
Name:
ROBERTS, BrianAddress:
Newark, CA, US
Name:
WANG, XueyanAddress:
Newark, CA, US
Name:
CHOI, Yun-JungAddress:
Newark, CA, US
Name:
KARPF, DavidAddress:
Newark, CA, US
Name:
MARTIN, RobertAddress:
Newark, CA, US
Name:
MCWHERTER, Charles A.Address:
Newark, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461978335 PDate:
11.4.2014Country:
US
Classification
Categories:
A61K 31/33, A61P 1/16
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 10.3.2020
Expires: 9.4.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.3.2021
Expires: 9.4.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.3.2022
Expires: 9.4.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.3.2023
Expires: 9.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.3.2024
Expires: 9.4.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 14.3.2025
Expires: 9.4.2026
Payer: Árnason Faktor ehf.